FID123361

FID123361 is an investigational ophthalmic formulation being evaluated as an ocular lubricant or dry eye therapy in clinical studies. Its precise mechanism of action and detailed pharmacology remain undisclosed in the public domain as of the current date. FID123361 has primarily been studied in the context of dry eye disease, where it is being compared to other test formulations and standard ocular lubricants in randomized controlled trials[5][7][1]. The drug is usually administered topically as an eye drop in clinical trial protocols. The developer or manufacturer information has not been made publicly available.